Allstate’s (ALL) Underperform Rating Reiterated at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods restated their underperform rating on shares of Allstate (NYSE:ALL) in a report published on Thursday morning, MarketBeat reports. The firm currently has a $250.00 price objective on the insurance provider’s stock, down from their previous price objective of $255.00.

A number of other brokerages have also issued reports on ALL. Weiss Ratings raised Allstate from a “buy (a-)” rating to a “buy (a)” rating in a report on Thursday, August 6th. UBS Group lifted their target price on Allstate from $261.00 to $275.00 and gave the company a “neutral” rating in a research note on Monday, August 10th. Citigroup lowered Allstate from a “neutral” rating to a “sell” rating and boosted their price target for the stock from $226.00 to $240.00 in a research report on Tuesday, August 11th. Evercore set a $240.00 price target on Allstate in a research note on Friday, July 10th. Finally, JPMorgan Chase & Co. raised their price target on Allstate from $282.00 to $292.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. Four research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have given a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $265.26.

Allstate Trading Down 0.3%

Shares of NYSE:ALL opened at $253.82 on Thursday. The company has a market cap of $64.18 billion, a PE ratio of 5.07, a P/E/G ratio of 0.39 and a beta of 0.16. The company’s 50-day moving average price is $250.34 and its 200 day moving average price is $224.95. Allstate has a fifty-two week low of $188.08 and a fifty-two week high of $277.22. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.24.

Allstate (NYSE:ALL) last posted its earnings results on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, topping the consensus estimate of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The firm had revenue of $18.60 billion during the quarter, compared to analysts’ expectations of $15.46 billion. During the same quarter in the prior year, the firm earned $5.94 EPS. Allstate’s quarterly revenue was up 11.8% on a year-over-year basis. Sell-side analysts anticipate that Allstate will post 34.45 earnings per share for the current year.

Allstate Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be given a $1.08 dividend. The ex-dividend date is Monday, August 31st. This represents a $4.32 annualized dividend and a yield of 1.7%. Allstate’s payout ratio is 8.63%.

Insider Buying and Selling at Allstate

In other news, insider John E. Dugenske sold 32,996 shares of Allstate stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $269.33, for a total value of $8,886,812.68. Following the transaction, the insider owned 13,054 shares of the company’s stock, valued at $3,515,833.82. The trade was a 71.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Mario Rizzo sold 56,225 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the completion of the sale, the chief operating officer owned 82,227 shares in the company, valued at $21,747,396.96. The trade was a 40.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 91,446 shares of company stock valued at $24,208,675. 1.55% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ALL. Brighton Jones LLC boosted its stake in shares of Allstate by 60.2% during the 4th quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock worth $1,253,000 after acquiring an additional 2,443 shares in the last quarter. Revolve Wealth Partners LLC purchased a new stake in shares of Allstate during the fourth quarter valued at $231,000. WINTON GROUP Ltd purchased a new stake in shares of Allstate during the second quarter valued at $210,000. Treasurer of the State of North Carolina boosted its position in shares of Allstate by 2.5% in the 2nd quarter. Treasurer of the State of North Carolina now owns 123,272 shares of the insurance provider’s stock valued at $24,816,000 after purchasing an additional 3,051 shares during the period. Finally, Ieq Capital LLC boosted its position in shares of Allstate by 20.1% in the 2nd quarter. Ieq Capital LLC now owns 38,316 shares of the insurance provider’s stock valued at $7,713,000 after purchasing an additional 6,412 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Trending Headlines about Allstate

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Allstate Company Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.